NEW YORK (GenomeWeb News) – Pressure BioSciences said in its quarterly earnings document that it may not be able to fund its operations beyond next month.

In its Form 10-Q filed with the US Securities and Exchange Commission on Thursday, the South Easton, Mass.-based company said that as of June 30, it had $113,663 in cash and cash equivalents and warned that it will need "substantial additional capital" to fund operations beyond the end of September 2013.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.